Pharma PRs after close today. Thursday July 25, 2

Pharma PRs after close today.

Thursday July 25, 2013

• Sorenson Communications' Video Center to Showcase Deaflympics Video Coverage
  7:15 pm - Marketwire


• Takeda Announces Unblinding of Phase 3 Study of Orteronel in Patients with Metastatic, Castration-Resistant Prostate Cancer That Progressed Post-Chemotherapy Based on Interim Analysis
  7:00 pm - Business Wire


• Adept Technology Delivers New Generation of Autonomous Mobile Robots to Swisslog
  6:00 pm - GlobeNewswire


• Sensient Technologies Corporation Reports Results for the Second Quarter Ended June 30, 2013
  5:50 pm - Business Wire


• Cepheid Receives FDA Market Authorization for Xpert MTB/RIF
  5:29 pm - PR Newswire


• New York Medical Malpractice Lawyers at Fitzgerald & Fitzgerald Settle Birth Injury Lawsuit for $3,500,000.00
  5:25 pm - Marketwire


• CHMP Confirms Prior Opinion Regarding Marketing Authorization in Europe for Pfizer’s XELJANZ® (tofacitinib citrate)
  5:09 pm - Business Wire


• Biologix Hair Inc. Announces Going Private Strategy, Delisting and Deregistration
  5:01 pm - Marketwire


• Thallion Announces 2013 Second Quarter Operating Results
  5:00 pm - Marketwire


• Trimel to Report Second Quarter 2013 Results and Host Investor Call
  5:00 pm - Marketwire


• U.S. FDA Acknowledges Receipt of Resubmission of the New Drug Application for Investigational Compound Dapagliflozin for the Treatment of Type 2 Diabetes
  5:00 pm - Business Wire


• Thallion Announces 2013 Second Quarter Operating Results
  5:00 pm - Marketwire


• Dignity Health and Alliance HealthCare Services Announce Partnership
  5:00 pm - Business Wire


• Thallion annonce ses résultats d'exploitation pour le deuxième trimestre de 2013
  5:00 pm - Marketwire


• Baxano Surgical, Inc. Schedules Second Quarter 2013 Results Conference Call for Thursday, August 8, 2013
  4:44 pm - GlobeNewswire


• Biologix Hair Inc. Announces Going Private Strategy, Delisting and Deregistration
  4:44 pm - Marketwire


• Nashville Based Outpatient Imaging Affiliates (“OiA”) Acquires Three Centers
  4:44 pm - Business Wire


• NASDAQ Welcomes Cellular Dynamics International, Inc. to The NASDAQ Stock Market
  4:39 pm - GlobeNewswire


• Merrimack Pharmaceuticals Announces Timing of Second Quarter 2013 Investor Conference Call
  4:30 pm - GlobeNewswire


• IMS Health to Issue Second-Quarter 2013 Financial Results on July 30, Conference Call for Note Holders Scheduled for July 31
  4:20 pm - Business Wire


• Amgen Announces Webcast of 2013 Second Quarter Financial Results
  4:14 pm - PR Newswire


• Arena Pharmaceuticals' BELVIQ® (lorcaserin HCl) CIV Nominated for 2013 Prix Galien USA Award
  4:12 pm - PR Newswire


• Medivation Announces Second Quarter 2013 Financial Results Teleconference on August 8, 2013
  4:10 pm - Marketwire


• IRIDEX Announces Second Quarter 2013 Conference Call and Release Date
  4:05 pm - PR Newswire


• Greatbatch, Inc. Reports 2013 Second Quarter Results
  4:05 pm - Business Wire


• Theravance Reports Second Quarter 2013 Financial Results
  4:05 pm - Marketwire


• Gilead Sciences Announces Second Quarter 2013 Financial Results
  4:05 pm - Business Wire


• BioMarin Provides BMN 673 Program Update
  4:05 pm - GlobeNewswire


• Alphatec Spine Announces Date for Release of Second Quarter 2013 Financial Results
  4:05 pm - GlobeNewswire


• Vertex Provides Update on Ongoing All-Oral Studies of VX-135 in Hepatitis C
  4:04 pm - Business Wire


• Neurocrine Biosciences Reports Second Quarter 2013 Results
  4:02 pm - PR Newswire


• IGI Laboratories Announces 2nd Quarter 2013 Results
  4:02 pm - Business Wire


• Mettler-Toledo International Inc. Reports Second Quarter 2013 Results
  4:01 pm - PR Newswire


• Edwards Lifesciences Reports Solid Second Quarter Results
  4:01 pm - Marketwire


• Express Scripts To Discuss Outlook for Future Growth
  4:01 pm - PR Newswire


• EnteroMedics Announces PMA Application for VBLOC Therapy in Obesity Accepted for Review and Filing by FDA
  4:01 pm - Marketwire


• TESARO Announces Second-Quarter 2013 Operating Results
  4:01 pm - GlobeNewswire


• The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
  4:00 pm - PR Newswire


• Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2014
  4:00 pm - PR Newswire


• BioMarin Announces Second Quarter 2013 Financial Results
  4:00 pm - GlobeNewswire